Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic conditions characterised by airway inflammation and restricted airflow. Medications in this category include bronchodilators and corticosteroids, which function by relaxing the smooth muscles of the airways and reducing internal swelling to facilitate easier breathing. These treatments are essential for both immediate symptom relief and long-term prevention of respiratory attacks. We offer these regulated treatments in various inhaler and oral formats to support pulmonary health.
Budesonide / Formoterol Fumarate Dihydrate
100/6|200/6|400/6mcg
Asthma and chronic breathing conditions affect the way air moves in and out of the lungs, often causing wheeze, shortness of breath and tightness in the chest. For many people, managing these symptoms involves a combination of inhaled and oral medications that can both relieve an immediate episode and reduce the likelihood of future attacks.
The goal of medication in this area is to keep the airways open, lessen inflammation, and help the individual maintain normal daily activities such as work, school or exercise. Medications such as Salbutamol, Budesonide and Montelukast are commonly used to address the range of needs that arise from asthma and related breathing disorders.
People may use these medicines during an acute flare-up, as a routine maintenance plan, or when living with conditions like Chronic Obstructive Pulmonary Disease (COPD). Understanding the different types of medicines and when they are typically taken can help patients recognise which options fit their own lifestyle.
Typical symptoms include wheezing, coughing (especially at night or early morning), chest tightness and a reduced ability to perform vigorous activities. These symptoms can interfere with work, schooling, sports and simple everyday tasks such as climbing stairs.
Each related category addresses a different aspect of respiratory health, complementing the core asthma and breathing medicines.
Bronchodilators - quickly relax the smooth muscle around the airways, opening them for easier airflow.
Inhaled Corticosteroids (ICS) - reduce airway inflammation when used regularly, helping to prevent future attacks.
Combination Inhalers (ICS + LABA) - pair an anti-inflammatory steroid with a long-acting bronchodilator for convenient maintenance therapy.
Anticholinergics - block a nerve signal that can cause airway narrowing, useful particularly in COPD.
Leukotriene Receptor Antagonists - oral tablets that block inflammatory chemicals called leukotrienes, helping to control both asthma and allergic components.
Phosphodiesterase-4 Inhibitors - oral medication that reduces inflammation in COPD and helps maintain lung function.
Anti-fibrotic Agents - used in certain progressive lung diseases to slow tissue scarring.
These groups cover the principal therapeutic strategies for breathing disorders without delving into individual dosing or safety details.
Asthma management typically follows a stepped approach, beginning with a rescue bronchodilator for quick symptom relief and adding anti-inflammatory inhalers if attacks become frequent. COPD treatment often emphasises long-acting bronchodilators and, where appropriate, inhaled steroids to control chronic inflammation.
Medication may be taken via metered-dose inhalers, dry-powder inhalers or, for some oral agents, tablets and capsules. The delivery device influences how the medicine reaches the lungs, and many patients find one type easier to use than another.
In acute situations, a rapid-acting bronchodilator is the preferred option, while long-acting agents are designed for regular use to maintain steady airway calibre. Understanding the distinction between “relief” and “maintenance” medicines helps patients recognise the purpose of each prescription they receive.
These scenarios illustrate the variety of everyday situations where asthma and breathing medicines play a role.
Bronchodilator: A drug that relaxes airway muscles, widening the breathing passages.
Inhaled corticosteroid: A medication delivered to the lungs to lower inflammation over time.
Long-acting β2-agonist (LABA): A bronchodilator that works for several hours, usually combined with an inhaled steroid.
Rescue inhaler: A short-acting bronchodilator used for sudden breathlessness.
Peak flow: A simple test that measures the fastest speed of exhaled air, helping to monitor asthma control.
A rescue inhaler contains a fast-acting bronchodilator that quickly opens the airways during an unexpected episode of breathlessness, providing rapid symptom relief.
Maintenance inhalers contain anti-inflammatory agents or long-acting bronchodilators that are taken regularly to keep the airways stable, whereas rescue inhalers are used only when symptoms suddenly appear.
Certain oral agents, such as leukotriene receptor antagonists and phosphodiesterase-4 inhibitors, are sometimes added to an inhaler regimen to help control inflammation or COPD-related symptoms.
Common devices include metered-dose inhalers (MDIs), dry-powder inhalers (DPIs) and soft-mist inhalers, each designed to release medication directly into the lungs.
Combining an inhaled corticosteroid with a long-acting bronchodilator in a single inhaler simplifies treatment by delivering both anti-inflammatory and bronchodilating action together.
Anticholinergics are mainly used in COPD, but they can be added to asthma treatment when additional bronchodilation is required.
Many patients check peak flow once or twice daily, especially when symptoms change, to track airway stability over time.
Techniques such as breathing exercises, regular physical activity and avoidance of known triggers can complement medication in managing asthma and COPD.
Asthma usually involves reversible airway narrowing and a strong allergic component, while COPD is characterised by irreversible damage to the lung tissue and is often linked to smoking history.
Modern inhalers with dose counters, ergonomic designs and quieter operation can make it easier for patients to use their medication correctly, supporting consistent treatment.
